Author

G. Schotta

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:chromatin & epigenetic regulation· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

F. M. Cernilogar· 2 shared A. Buschle· 1 shared A. Schneeweiss· 1 shared A. Trumpp· 1 shared A. Yeroslaviz· 1 shared C. H. Scheel· 1 shared C. Klein· 1 shared D. Pich· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. M. Cernilogar

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

β1 integrin signaling governs necroptosis via the chromatin remodeling factor CHD4

Z. Sun, F. M. Cernilogar, H. Horvatic, A. Yeroslaviz, Z. Abdullah, G. Schotta, V. Hornung

The paper shows that β1 integrin signaling regulates necroptosis through CHD4-mediated repression of Ripk3 in fibrosis.

bioRxiv · Apr 14, 2023Immunology

Maintenance of epithelial traits and resistance to mesenchymal reprogramming promote proliferation in metastatic breast cancer

L. Eichelberger, M. Saini, H. D. Moreno, C. Klein, J. M. Bartsch, M. Falcone, M. Reitberger, E. Espinet, V. Vogel, E. Graf, T. Schwarzmayr, T.-M. Strom, M. Lehmann, M. Koenigshoff, N. Pfarr, , C. H. Scheel

This study shows that high EPCAM expression in metastatic breast cancer cells supports epithelial traits and plasticity, promoting metastatic outgrowth, while loss of epithelial traits inhibits it.

bioRxiv · Mar 19, 2020 · PreprintCancer Biology

Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation

A. Buschle, P. Mrozek-Gorska, S. Krebs, H. Blum, F. M. Cernilogar, G. Schotta, D. Pich, T. Straub, W. Hammerschmidt

This study shows that EBV lytic reactivation causes global chromatin remodeling and transcriptome disruption in host cells before viral DNA replication.

bioRxiv · Mar 20, 2019Cell Biology